Article
EBV infection-induced GPX4 promotes chemoresistance and tumor progression in nasopharyngeal carcinoma
1 Feb 2022
Abstract excerpt
Epstein-Barr virus (EBV) was the first oncogenic virus identified in humans. It is primarily associated with multiple lymphoid and epithelial cancers, including nasopharyngeal carcinoma (NPC). However, its association with ferroptosis and its role in cancer therapy resistance have not been fully elucidated. Here, we show that EBV infection reduces the sensitivity of NPC cells to ferroptosis by activating the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
